-
Der receives grant funding for pancreatic cancer research
-
Channing Der, PhD, Sarah Graham Kenan Professor of Pharmacology, received a two-year $200,000 American Association for Cancer Research Innovative grant from the Pancreatic Cancer Action Network. His grant will fund research on the mechanism of ERK inhibition resistance and ERK-dependent pancreatic cancer.
Located in
News
/
2012 News
-
GenomeWeb: Researchers See Prognostic Hints in Pancreatic Cancer Tumor, Stroma Subtypes
-
Located in
Newsroom
/
UNC Lineberger in the News
-
Potential pancreatic cancer treatment could increase life expectancy
-
Device that drives drugs into solid tumors that are poorly vascularized opens the possibility of life-saving surgeries in cancer patients.
Located in
News
-
UNC researchers trade lab coats for running shoes
-
Kirsten Bryant, PhD, was recently recognized by the Pancreatic Cancer Action Network for her dual role in the fight against pancreatic cancer.
Located in
News
-
Device hits pancreatic tumors hard with toxic four-drug cocktail, sparing the body
-
A new implantable device delivers first-line treatment for pancreatic cancer directly to tumors, bypassing bloodstream and limiting widespread side effects. A team of researchers from the University of North Carolina including Drs. Jen Jen Yeh and Joseph DeSimone, has shown in preclinical research that the device can deliver a particularly toxic dose of drugs directly to pancreatic tumors to stunt their growth or, in some cases, shrink them. This approach would also spare the patient toxic side effects.
Located in
News
-
Trainee Kirsten Bryant Awarded AACR Pathway to Leadership Grant
-
The Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant represents a joint effort to ensure the future leadership of pancreatic cancer research by supporting outstanding early career investigators beginning in their postdoctoral research positions and continuing through their successful transition to independence.
Located in
News
-
Medical Xpress: Pancreatic cancer subtypes discovered in largest gene expression analysis to date
-
Located in
Newsroom
/
UNC Lineberger in the News
-
Advocates join together to raise awareness about pancreatic cancer
-
When scientists and advocates join forces, good things can happen. Dr. Channing Der, Sarah Graham Kenan Professor of Pharmacology and UNC Lineberger faculty member, and Lori Matteson, a Raleigh pancreatic cancer survivor and advocate, joined over 600 other pancreatic cancer advocates and family members on a visit to Washington, DC.
Located in
News
/
2012 News
-
UNC Lineberger teams to participate in Pancreatic Cancer Purple Stride 5K
-
UNC Lineberger will be well represented at the 2014 Pancreatic Cancer Purple Stride 5K. The event, organized by the Pancreatic Cancer Action Network, helps raise awareness and research funds for pancreatic cancer.
Located in
News
-
USA Today looks at pancreatic cancer, Goldberg quoted
-
Richard Goldberg, MD, physician-in-chief of the N.C. Cancer Hospital, is quoted in the Health section of USA Today's website.
Located in
News
/
2011 News